Skip to main navigation Skip to search Skip to main content

Cardio-oncology: Capecitabine Can Sometimes be Heatbreaking Capecitabine-Induced Takotsubo Cardiomyopathy Case Report and Literature Review.

  • Ramy Abdelmaseih
  • , Anamarys Blanco
  • , Randa Abdelmasih
  • , Krutika Desai
  • , Joshua J Pothen
  • , Jay Patel
  • , Rama Balaraman
    • HCA Healthcare

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Capecitabine has been more recognized for its cardiotoxicity with an incidence that varies widely. It demonstrates its toxicity in the forms of acute coronary syndrome, arrhythmias and, to a lesser extent, cardiomyopathy. There are several proposed theories including coronary vasospasm, endothelial injury, and oxidative stress. We present a case of capecitabine-induced cardiomyopathy in a patient with pancreatic cancer and mild coronary artery disease, and shed light on other cardio-toxic agents, their proposed mechanism of cardiotoxicity, and on cardiomyopathy in general.

    Original languageAmerican English
    JournalInternal Medicine
    StatePublished - Aug 1 2021

    Keywords

    • Capecitabine
    • Humans
    • Incidence
    • Neoplasms
    • Takotsubo Cardiomyopathy

    Disciplines

    • Cardiology
    • Cardiovascular Diseases
    • Internal Medicine

    Cite this